CROSS CTRY HEALTHCARE INC's ticker is CCRN and the CUSIP is 227483104. A total of 99 filers reported holding CROSS CTRY HEALTHCARE INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $40,817,000 | +51.3% | 2,614,775 | +14.2% | 0.01% | +33.3% |
| Q3 2016 | $26,970,000 | -8.8% | 2,289,490 | +7.8% | 0.01% | -14.3% |
| Q2 2016 | $29,566,000 | +23.2% | 2,123,987 | +2.9% | 0.01% | +16.7% |
| Q1 2016 | $24,002,000 | -30.1% | 2,063,819 | -1.4% | 0.01% | -25.0% |
| Q4 2015 | $34,323,000 | +27.8% | 2,094,145 | +6.1% | 0.01% | +14.3% |
| Q3 2015 | $26,864,000 | +14.0% | 1,973,840 | +6.2% | 0.01% | +16.7% |
| Q2 2015 | $23,567,000 | +8.9% | 1,858,585 | +1.9% | 0.01% | +20.0% |
| Q1 2015 | $21,639,000 | -0.2% | 1,824,561 | +5.0% | 0.01% | 0.0% |
| Q4 2014 | $21,688,000 | +48.9% | 1,737,783 | +10.8% | 0.01% | +25.0% |
| Q3 2014 | $14,569,000 | +43.8% | 1,568,257 | +0.9% | 0.00% | +33.3% |
| Q2 2014 | $10,133,000 | -19.9% | 1,554,104 | -0.9% | 0.00% | -25.0% |
| Q1 2014 | $12,655,000 | -18.6% | 1,568,183 | +0.7% | 0.00% | -20.0% |
| Q4 2013 | $15,543,000 | +68.8% | 1,557,464 | +2.2% | 0.01% | +66.7% |
| Q3 2013 | $9,209,000 | +18.0% | 1,524,638 | +0.8% | 0.00% | 0.0% |
| Q2 2013 | $7,803,000 | – | 1,512,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 305,925 | $2,671,000 | 1.43% |
| Benefit Street Partners LLC | 1,339,640 | $11,695,000 | 0.83% |
| SKYLINE ASSET MANAGEMENT LP | 956,489 | $8,350,000 | 0.74% |
| Aristotle Capital Boston, LLC | 1,001,236 | $8,741,000 | 0.64% |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 751,859 | $6,563,000 | 0.59% |
| HEARTLAND ADVISORS INC | 768,390 | $6,708,000 | 0.45% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 904,900 | $7,900,000 | 0.36% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 854,010 | $7,456,000 | 0.18% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 89,186 | $779,000 | 0.16% |
| J. Goldman & Co LP | 229,393 | $2,003,000 | 0.14% |